RUCHI PATEL: Open Payments
NPI 1831550003 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,157 in 179 payments from 27 companies in 2025. Trend: 2023 $5,068 · 2024 $5,518 · 2025 $6,157
Food & beverage: $5,957Education: $200
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $1,116 |
| Janssen Biotech, Inc. | 24 | $1,059 |
| ABBVIE INC. | 17 | $704 |
| GENZYME CORPORATION | 11 | $498 |
| LEO Pharma Inc. | 10 | $488 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $288 |
| Galderma Laboratories, L.P. | 14 | $219 |
| UCB, Inc. | 7 | $184 |
| E.R. Squibb & Sons, L.L.C. | 2 | $156 |
| Regeneron Pharmaceuticals, Inc. | 2 | $154 |
Products named: TREMFYA, DUPIXENT, RINVOQ, ADBRY, COSENTYX, Rhapsido, ILUMYA, SKYRIZI.
Industry payments across TN — which companies pay providers there.
